Literature DB >> 1290695

ARCON: accelerated radiotherapy with carbogen and nicotinamide.

A Rojas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1290695

Source DB:  PubMed          Journal:  BJR Suppl        ISSN： 0961-2653


× No keyword cloud information.
  10 in total

Review 1.  Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.

Authors:  M Saunders; S Dische
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content.

Authors:  M W Dewhirst; E T Ong; G L Rosner; S W Rehmus; S Shan; R D Braun; D M Brizel; T W Secomb
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 3.  Clinical significance of cellular resistance in tumours to cytotoxic chemotherapy and radiotherapy.

Authors:  M Pomeroy; M Moriarty
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 4.  Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide.

Authors:  Seon Beom Song; Jin Sung Park; Gu June Chung; In Hye Lee; Eun Seong Hwang
Journal:  Metabolomics       Date:  2019-10-05       Impact factor: 4.290

5.  Use of power Doppler ultrasound-guided biopsies to locate regions of tumour hypoxia.

Authors:  S M Evans; K M Laughlin; C R Pugh; C M Sehgal; H M Saunders
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging.

Authors:  S P Robinson; L M Rodrigues; A S Ojugo; P M McSheehy; F A Howe; J R Griffiths
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.

Authors:  A Rojas; R J Hodgkiss; M R Stratford; M F Dennis; H Johns
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

8.  Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.

Authors:  P J Hoskin; M I Saunders; H Phillips; H Cladd; M E Powell; K Goodchild; M R Stratford; A Rojas
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients.

Authors:  V M Laurence; R Ward; I F Dennis; N M Bleehen
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

10.  Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined.

Authors:  D J Honess; N M Bleehen
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.